Moderna, Merck’s experimental cancer vaccine cuts melanoma recurrence risk by 42%: Report
We haven't written up this one. The Indian Express - Lifestyle has the full story — the link below goes straight to it.
More in Health & Medicine
Wa West records 92% yellow fever vaccination
Yellow fever vaccination in Wa West District has hit 92%, with the Ghana Health Service Director-General Dr. Samuel Kaba Akoriyea, declaring that the vaccine is free, dry, very safe and…
Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy?
Key PointsPJP targets companies in the pharmaceuticals sector, while IBB targets biotech stocks.
Mounjaro rollout on NHS needs 'urgent' boost, say MPs
Plans for rolling out weight-loss drug Mounjaro are "unambitious" and will reach a "woefully small number of people", according to MPs.
São Paulo Saliva Tests Find Fentanyl in 32%
Researchers at the University of São Paulo found fentanyl in the saliva of 32% of 65 synthetic cannabinoid users, none of whom reported taking opioids.
Nigeria: Tinubu's N10bn Ebola Emergency Fund Still Untouched, APC Campaign Council Replies Atiku
[Premium Times] The APC Presidential Campaign Council says the ₦10 billion approved for Ebola preparedness in June has not been spent, rejecting Atiku Abubakar's criticism of the federal government's…
Africa: Gavi and Unicef Secure Lower Malaria Vaccine Price, Saving U.S.$50 Million for Childhood Immunization Programmes
[Unicef] Copenhagen/Geneva/New York -- An agreement announced today will cut the price of the RTS,S/AS01 malaria vaccine by approximately 40 per cent.